Description
Development of an innovative oral formulation of DHEA for the treatment of hot flashes in postmenopausal women.
Amendment chain · 4 entries
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $649,840 at start, $416,200 after amendment #6 (−$233,640).
- #02019-08-05$649,840
- #42021-03-23$649,840
- #52022-01-26$649,840
- #62022-09-08$416,200-$233,640
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2019-08-05(start date) | $649,840 | — | Development of an innovative oral formulation of DHEA for the treatment of hot flashes in postmenopausal women… |
| #4 amendment | 2021-03-23 | $649,840 | +$0 | Development of an innovative oral formulation of DHEA for the treatment of hot flashes in postmenopausal women… |
| #5 amendment | 2022-01-26 | $649,840 | +$0 | Development of an innovative oral formulation of DHEA for the treatment of hot flashes in postmenopausal women… |
| #6 amendment | 2022-09-08 | $416,200 | −$233,640 | Development of an innovative oral formulation of DHEA for the treatment of hot flashes in postmenopausal women… |
Related records · 6
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 850923327)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 172-2018-2019-Q3-917244 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $50,000 | FY2019 |
Other recipients funded under "Industrial Research Assistance Program – Contributions to Firms" by National Research Council Canada | Conseil national de recherches Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 172-2025-2026-Q2-1034675 | Mediphage Bioceuticals, Inc. | FY2027 | $63,380 | FY2027 |
| 172-2025-2026-Q3-1037522 | OBKIO INC. | FY2026 | $50,000 | FY2026 |
| 172-2025-2026-Q3-1037889 | SERVICES DE DEVELOPPEMENT PROFESSIONELS SDP INC | FY2026 | $25,000 | FY2026 |
| 172-2025-2026-Q2-1034040 | Griffith Foods Limited | FY2026 | $54,880 | FY2026 |
| 172-2025-2026-Q3-1037273 | Apollo Machine & Welding Ltd. | FY2026 | $230,000 | FY2026 |
Cite as: Glassbox record view · Federal grants & contributions · 172-2019-2020-Q2-932356 · retrieved 2026-11-15.